Acute inflammatory responses of nanoparticles in an intra-tracheal instillation rat model

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Armstead, Andrea L ^a   Minarchick, Valerie C ^b,c   Porter, Dale W ^b,d   Nurkiewicz, Timothy R ^b,c,d   Biomaterials, Bingyun Li ^a,d  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERIUM DIOXIDE NANOPARTICLE; CYTOKINE; METAL NANOPARTICLE; TUNGSTEN CARBIDE COBALT NANOPARTICLE; UNCLASSIFIED DRUG; COBALT; INTERLEUKIN 6; NANOPARTICLE; TUMOR NECROSIS FACTOR; TUNGSTEN CARBIDE; TUNGSTEN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; IN VIVO STUDY; INFLAMMATION; INTRATRACHEAL INSTILLATION; LUNG LAVAGE; MALE; NANOTOXICOLOGY; NONHUMAN; PNEUMONIA; PROCEDURES; RAT; TOXICITY TESTING; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TRACHEA;

ANIMALIA; RATTUS;

ANIMALS; BRONCHOALVEOLAR LAVAGE; COBALT; INFLAMMATION; INTERLEUKIN-6; MALE; NANOPARTICLES; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, ACUTE; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA; TUNGSTEN COMPOUNDS;

EID: 84928902771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118778     Document Type: Article

References (92)

1. Castranova V. Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med. 2011; 53: S14-S17. doi: 10.1097/JOM.0b013e31821b1e5a PMID: 21606847
2. Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, et al. Nanotechnology and human health: risks and benefits. J Appl Toxicol. 2010; 30: 730-744. doi: 10.1002/jat.1609 PMID: 21117037
3. Guadagnini R, Halamoda Kenzaoui B, Cartwright L, Pojana G, Magdolenova Z, Bilanicova D, et al. Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology. 2013; epub ahead of print: doi: 10.3109/17435390.17432013.17829590
4. Schrand AM, Dai L, Schlager JJ, Hussain SM. Toxicity testing of nanomaterials. Adv Exp Med Biol. 2012; 745: 58-75. doi: 10.1007/978-1-4614-3055-1-5 PMID: 22437813
5. Song Y, Li X, Wang L, Rojanasakul Y, Castranova V, Li H, et al. Nanomaterials in humans: identification, characteristics, and potential damage. Toxicol Pathol. 2011; 39: 841-849. doi: 10.1177/0192623311413787 PMID: 21768271
6. Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Moseley AM, Cumpston JL, et al. Pulmonary particulate matter and systemic microvascular dysfunction. Res Rep Health Eff Inst. 2011; 164: 3-48. PMID: 22329339
7. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012; 14: 1-16. doi: 10.1146/annurev-bioeng-071811-150124 PMID: 22524388
8. Hubbs AF, Mercer RR, Benkovic SA, Harkema J, Sriram K, Schwegler-Berry D, et al. Nanotoxicology - a pathologist's perspective. Toxicol Pathol. 2011; 39: 301-324. doi: 10.1177/0192623310390705 PMID: 21422259
9. Li JJ, Muralikrishnan S, Ng CT, Yung LY, Bay BH. Nanoparticle-induced pulmonary toxicity. Exp Biol Med (Maywood). 2010; 235: 1025-1033. doi: 10.1258/ebm.2010.010021 PMID: 20719818
10. Knuckles TL, Yi J, Frazer DG, Leonard HD, Chen BT, Castranova V, et al. Nanoparticle inhalation alters systemic arteriolar vasoreactivity through sympathetic and cyclooxygenase-mediated pathways. Nanotoxicology. 2012; 6: 724-735. doi: 10.3109/17435390.2011.606926 PMID: 21830860
11. LeBlanc AJ, Moseley AM, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc Toxicol. 2010; 10: 27-36. doi: 10.1007/s12012-009-9060-4 PMID: 20033351
12. Du Z, Zhao D, Jing L, Cui G, Jin M, Li Y, et al. Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc Toxicol. 2013; 13: 194-207. doi: 10.1007/s12012-013-9198-y PMID: 23322373
13. Geraets L, Oomen AG, Schroeter JD, Coleman VA, Cassee FR. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol Sci. 2012; 127: 463-473. doi: 10.1093/toxsci/kfs113 PMID: 22430073
14. He X, Zhang H, Ma Y, Bai W, Zhang Z, Lu K, et al. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology. 2010; 21: 285103. doi: 10.1088/0957-4484/21/28/285103 PMID: 20562477
15. McKinney W, Jackson M, Sager TM, Reynolds JS, Chen BT, Afshari A, et al. Pulmonary and cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing titanium dioxide nanoparticles. Inhal Toxicol. 2012; 24: 447-457. doi: 10.3109/08958378.2012.685111 PMID: 22642294
16. Minarchick VC, Stapleton PA, Porter DW, Wolfarth MG, Ciftyurek E, Barger M, et al. Pulmonary cerium dioxide nanoparticle exposure differentially impairs coronary and mesenteric arteriolar reactivity. Cardiovasc Toxicol. 2013; 13: 323-337. doi: 10.1007/s12012-013-9213-3 PMID: 23645470
17. Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Chen BT, Frazer DG, et al. Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci. 2009; 110: 191-203. doi: 10.1093/toxsci/kfp051 PMID: 19270016
18. Porter DW, Hubbs AF, Baron PA, Millecchia LL, Wolfarth MG, Battelli LA, et al. Pulmonary toxicity of Expancel microspheres in the rat. Toxicol Pathol. 2007; 35: 702-714. PMID: 17763284
19. Stapleton PA, Minarchick VC, McCawley M, Knuckles TL, Nurkiewicz TR. Xenobiotic particle exposure and microvascular endpoints: a call to arms. Microcirculation. 2012; 19: 126-142. doi: 10.1111/j.1549-8719.2011.00137.x PMID: 21951337
20. Yao Z, Stiglich J, Sudarshan T. Nanosized WC-Co holds promise for the future. Metal Powder Report. 1998; 53: 26-33.
21. Stefaniak AB, Day GA, Harvey CJ, Leonard SS, Schwegler-Berry DE, Chipera SJ, et al. Characteristics of dusts encountered during the production of cemented tungsten carbides. Ind Health. 2007; 45: 793-803. PMID: 18212475
22. Stefaniak AB, Virji MA, Day GA. Characterization of exposures among cemented tungsten carbide workers. Part I: Size-fractionated exposures to airborne cobalt and tungsten particles. J Expo Sci Environ Epidemiol. 2009; 19: 475-491. doi: 10.1038/jes.2008.37 PMID: 18628793
23. Balmes JR. Respiratory effects of hard-metal dust exposure. Occup Med. 1987; 2: 327-344. PMID: 3303384
24. Cugell DW. The hard metal diseases. Clin Chest Med. 1992; 13: 269-279. PMID: 1511554
25. Kraus T, Schramel P, Schaller KH, Zobelein P, Weber A, Angerer J. Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds. Occup Environ Med. 2001; 58: 631-634. PMID: 11555683
26. Nemery B, Abraham JL. Hard metal lung disease: still hard to understand. Am J Respir Crit Care Med. 2007; 176: 2-3. PMID: 17586761
27. Nemery B, Verbeken EK, Demedts M. Giant cell interstitial pneumonia (hard metal lung disease, cobalt lung). Semin Respir Crit Care Med. 2001; 22: 435-448. PMID: 16088691
28. Edel J, Sabbioni E, Pietra R, Rossi A, Torre M, Rizzato G, et al. Trace metal lung disease: in vitro interaction of hard metals with human lung and plasma components. Sci Total Environ. 1990; 95: 107-117. PMID: 2205918
29. Anard D, Kirsch-Volders M, Elhajouji A, Belpaeme K, Lison D. In vitro genotoxic effects of hard metal particles assessed by alkaline single cell gel and elution assays. Carcinogenesis. 1997; 18: 177-184. PMID: 9054604
30. Antonini JM, Starks K, Roberts JR, Millecchia L, Yang HM, Rao KM. Changes in F-actin organization induced by hard metal particle exposure in rat pulmonary epithelial cells using laser scanning confocal microscopy. In Vitr Mol Toxicol. 2000; 13: 5-16. PMID: 10900403
31. De Boeck M, Lombaert N, De Backer S, Finsy R, Lison D, Kirsch-Volders M. In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis. 2003; 18: 177-186. PMID: 12621074
32. Fedan JS, Cutler D. Hard metal-induced disease: effects of metal cations in vitro on guinea pig isolated airways. Toxicol Appl Pharmacol. 2001; 174: 199-206. PMID: 11485380
33. Lison D, Lauwerys R. In vitro cytotoxic effects of cobalt-containing dusts on mouse peritoneal and rat alveolar macrophages. Environ Res. 1990; 52: 187-198. PMID: 2168316
34. Lison D, Lauwerys R. Study of the mechanism responsible for the elective toxicity of tungsten carbide-cobalt powder toward macrophages. Toxicol Lett. 1992; 60: 203-210. PMID: 1570634
35. Lison D, Lauwerys R. Evaluation of the role of reactive oxygen species in the interactive toxicity of carbide-cobalt mixtures on macrophages in culture. Arch Toxicol. 1993; 67: 347-351. PMID: 8396391
36. Lombaert N, De Boeck M, Decordier I, Cundari E, Lison D, Kirsch-Volders M. Evaluation of the apoptogenic potential of hard metal dust (WC-Co), tungsten carbide and metallic cobalt. Toxicol Lett. 2004; 154: 23-34. PMID: 15475175
37. Lombaert N, Lison D, Van Hummelen P, Kirsch-Volders M. In vitro expression of hard metal dust (WC-Co) - responsive genes in human peripheral blood mononucleated cells. Toxicol Appl Pharmacol. 2008; 227: 299-312. PMID: 18078969
38. Roesems G, Hoet PH, Dinsdale D, Demedts M, Nemery B. In vitro cytotoxicity of various forms of cobalt for rat alveolar macrophages and type II pneumocytes. Toxicol Appl Pharmacol. 2000; 162: 2-9. PMID: 10631122
39. Sjogren I, Hillerdal G, Andersson A, Zetterstrom O. Hard metal lung disease: importance of cobalt in coolants. Thorax. 1980; 35: 653-659. PMID: 7444839
40. Zhang XD, Zhao J, Bowman L, Shi X, Castranova V, Ding M. Tungsten carbide-cobalt particles activate Nrf2 and its downstream target genes in JB6 cells possibly by ROS generation. J Environ Pathol Toxicol Oncol. 2010; 29: 31-40. PMID: 20528745
41. Bastian S, Busch W, Kuhnel D, Springer A, Meissner T, Holke R, et al. Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro. Environ Health Perspect. 2009; 117: 530-536. doi: 10.1289/ehp.0800121 PMID: 19440490
42. Armstead AL, Arena CB, Li B. Exploring the potential role of tungsten carbide cobalt (WC-Co) nanoparticle internalization in observed toxicity toward lung epithelial cells in vitro. Toxicol Appl Pharmacol. 2014; 278: 1-8. doi: 10.1016/j.taap.2014.04.008 PMID: 24746988
43. Adamis Z, Tatrai E, Honma K, Karpati J, Ungvary G. A study on lung toxicity of respirable hard metal dusts in rats. Ann Occup Hyg. 1997; 41: 515-526. PMID: 9332157
44. De Boeck M, Hoet P, Lombaert N, Nemery B, Kirsch-Volders M, Lison D. In vivo genotoxicity of hard metal dust: induction of micronuclei in rat type II epithelial lung cells. Carcinogenesis. 2003; 24: 1793-1800. PMID: 12949052
45. Huaux F, Lasfargues G, Lauwerys R, Lison D. Lung toxicity of hard metal particles and production of interleukin-1, tumor necrosis factor-alpha, fibronectin, and cystatin-c by lung phagocytes. Toxicol Appl Pharmacol. 1995; 132: 53-62. PMID: 7747285
46. Kerfoot EJ, Fredrick WG, Domeier E. Cobalt metal inhalation studies on miniature swine. Am Ind Hyg Assoc J. 1975; 36: 17-25. PMID: 1111264
47. Kitamura H, Yoshimura Y, Tozawa T, Koshi K. Effects of cemented tungsten carbide dust on rat lungs following intratracheal injection of saline suspension. Acta Pathol Jpn. 1980; 30: 241-253. PMID: 7386201
48. Lasfargues G, Lardot C, Delos M, Lauwerys R, Lison D. The delayed lung responses to single and repeated intratracheal administration of pure cobalt and hard metal powder in the rat. Environ Res. 1995; 69: 108-121. PMID: 8608770
49. Rengasamy A, Kommineni C, Jones JA, Fedan JS. Effects of hard metal on nitric oxide pathways and airway reactivity to methacholine in rat lungs. Toxicol Appl Pharmacol. 1999; 157: 178-191. PMID: 10373402
50. Lasfargues G, Lison D, Maldague P, Lauwerys R. Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in rat. Toxicol Appl Pharmacol. 1992; 112: 41-50. PMID: 1733047
51. Toya T, Takata A, Otaki N, Takaya M, Serita F, Yoshida K, et al. Pulmonary toxicity induced by intratracheal instillation of coarse and fine particles of cerium dioxide in male rats. Ind Health. 2010; 48: 3-11. PMID: 20160402
52. Ma JY, Zhao H, Mercer RR, Barger M, Rao M, Meighan T, et al. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology. 2011; 5: 312-325. doi: 10.3109/17435390.2010.519835 PMID: 20925443
53. Nurkiewicz TR, Porter DW, Barger M, Millecchia L, Rao KM, Marvar PJ, et al. Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure. Environ Health Perspect. 2006; 114: 412-419. PMID: 16507465
54. Nurkiewicz TR, Porter DW, Barger M, Castranova V, Boegehold MA. Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ Health Perspect. 2004; 112: 1299-1306. PMID: 15345343
55. Porter DW, Hubbs AF, Mercer RR, Wu N, Wolfarth MG, Sriram K, et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology. 2010; 269: 136-147. doi: 10.1016/j.tox.2009.10.017 PMID: 19857541
56. Dulin AM, Paape MJ, Weinland BT. Cytospin centrifuge in differential counts of milk somatic cells. J Dairy Sci. 1982; 65: 1247-1251. PMID: 7050194
57. Porter DW, Millecchia LL, Willard P, Robinson VA, Ramsey D, McLaurin J, et al. Nitric oxide and reactive oxygen species production causes progressive damage in rats after cessation of silica inhalation. Toxicol Sci. 2006; 90: 188-197. PMID: 16339787
58. Castranova V, Huffman LJ, Judy DJ, Bylander JE, Lapp LN, Weber SL, et al. Enhancement of nitric oxide production by pulmonary cells following silica exposure. Environ Health Perspect. 1998; 106 Suppl 5: 1165-1169. PMID: 9788892
59. Allen RC. Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes. Infect Immun. 1977; 15: 828-833. PMID: 323143
60. Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY, Maples KR, et al. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundament Appl Toxicol. 1995; 24: 183-197. PMID: 7737430
61. Miyata R, van Eeden SF. The innate and adaptive immune response induced by alveolar macrophages exposed to ambient particulate matter. Toxicol Appl Pharmacol. 2011; 257: 209-226. doi: 10.1016/j.taap.2011.09.007 PMID: 21951342
62. Geiser M. Morphological aspects of particle uptake by lung phagocytes. Microsc Res Tech. 2002; 57: 512-522. PMID: 12112434
63. Donaldson K, Schinwald A, Murphy F, Cho WS, Duffin R, Tran L, et al. The biologically effective dose in inhalation nanotoxicology. Acc Chem Res. 2013; 46: 723-732. doi: 10.1021/ar300092y PMID: 23003923
64. Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L817-829. doi: 10.1152/ajplung.00442.2007 PMID: 18263666
65. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med. 2004; 61: 442-447. PMID: 15090666
66. Silva RM, Teesy C, Franzi L, Weir A, Westerhoff P, Evans JE, et al. Biological response to nano-scale titanium dioxide (TiO2): role of particle dose, shape, and retention. J Toxicol Environ Health A. 2013; 76: 953-972. doi: 10.1080/15287394.2013.826567 PMID: 24156719
67. Tada Y, Yano N, Takahashi H, Yuzawa K, Ando H, Kubo Y, et al. Acute phase pulmonary responses to a single intratracheal spray instillation of magnetite (fe(3)o(4)) nanoparticles in Fischer 344 rats. J Toxicol Pathol. 2012; 25: 233-239. doi: 10.1293/tox.25.233 PMID: 23345925
68. Dunlop P, Muller NL, Wilson J, Flint J, Churg A. Hard metal lung disease: high resolution CT and histologic correlation of the initial findings and demonstration of interval improvement. J Thorac Imaging. 2005; 20: 301-304. PMID: 16282911
69. Moriyama H, Kobayashi M, Takada T, Shimizu T, Terada M, Narita J, et al. Two-dimensional analysis of elements and mononuclear cells in hard metal lung disease. Am J Respir Crit Care Med. 2007; 176: 70-77. PMID: 17363774
70. Naqvi AH, Hunt A, Burnett BR, Abraham JL. Pathologic spectrum and lung dust burden in giant cell interstitial pneumonia (hard metal disease/cobalt pneumonitis): review of 100 cases. Arch Environ Occup Health. 2008; 63: 51-70. doi: 10.3200/AEOH.63.2.51-70 PMID: 18628077
71. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006; 311: 622-627. PMID: 16456071
72. Seale-Goldsmith MM, Leary JF. Nanobiosystems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009; 1: 553-567. doi: 10.1002/wnan.49 PMID: 20049817
73. Srimok B, Yim MS. Examining the importance of the particle size effect in inhalation dose assessment for short-term radiological events. Radiat Prot Dosim. 2011; 147: 439-450. doi: 10.1093/rpd/ncq488 PMID: 21156784
74. Kim KP, Wu CY, Birky BK, Bolch WE. Influence of particle size distribution on inhalation doses to workers in the Florida phosphate industry. Health Physics. 2006; 91: 58-67. PMID: 16775481
75. Bernstein D. A review of the influence of particle size, puff volume, and inhalation pattern on the deposition of cigarette smoke particles in the respiratory tract. Inhal Toxicol. 2004; 16: 675-689. PMID: 15371056
76. Cassee FR, Muijser H, Duistermaat E, Freijer JJ, Geerse KB, Marijnissen JC, et al. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch Toxicol. 2002; 76: 277-286. PMID: 12107645
77. Borm PJ, Schins RP, Albrecht C. Inhaled particles and lung cancer, part B: paradigms and risk assessment. Int J Cancer. 2004; 110: 3-14. PMID: 15054863
78. Institute IRS. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol. 2000; 12: 1-17. PMID: 12881884
79. Knaapen AM, Borm PJ, Albrecht C, Schins RP. Inhaled particles and lung cancer. Part A: Mechanisms. Int J Cancer. 2004; 109: 799-809. PMID: 15027112
80. Warheit DB. Assessing health risks of inhaled nanomaterials: development of pulmonary bioassay hazard studies. Anal Bioanal Chem. 2010; 398: 607-612. doi: 10.1007/s00216-010-4000-5 PMID: 20665009
81. Zhu MT, Feng WY, Wang Y, Wang B, Wang M, Ouyang H, et al. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci. 2009; 107: 342-351. doi: 10.1093/toxsci/kfn245 PMID: 19023088
82. Pauluhn J, Wiemann M. Siderite (FeCO(3)) and magnetite (Fe(3)O(4)) overload-dependent pulmonary toxicity is determined by the poorly soluble particle not the iron content. Inhal Toxicol. 2011; 23: 763-783. doi: 10.3109/08958378.2011.606431 PMID: 22035119
83. Pauluhn J. Subchronic inhalation toxicity of iron oxide (magnetite, Fe(3) O(4)) in rats: pulmonary toxicity is determined by the particle kinetics typical of poorly soluble particles. J Appl Toxicol. 2012; 32: 488-504. doi: 10.1002/jat.1668 PMID: 21456093
84. Blum JL, Rosenblum LK, Grunig G, Beasley MB, Xiong JQ, Zelikoff JT. Short-term inhalation of cadmium oxide nanoparticles alters pulmonary dynamics associated with lung injury, inflammation, and repair in a mouse model. Inhal Toxicol. 2014; 26: 48-58. doi: 10.3109/08958378.2013.851746 PMID: 24417406
85. Gustafsson A, Lindstedt E, Elfsmark LS, Bucht A. Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat. J Immunotoxicol. 2011; 8: 111-121. doi: 10.3109/1547691X.2010.546382 PMID: 21309687
86. Haberl N, Hirn S, Wenk A, Diendorf J, Epple M, Johnston BD, et al. Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats. Beilstein J Nanotechn. 2013; 4: 933-940. doi: 10.3762/bjnano.4.105 PMID: 24455451
87. Courbiere B, Auffan M, Rollais R, Tassistro V, Bonnefoy A, Botta A, et al. Ultrastructural interactions and genotoxicity assay of cerium dioxide nanoparticles on mouse oocytes. Int J Mol Sci. 2013; 14: 21613-21628. doi: 10.3390/ijms141121613 PMID: 24185910
88. Gaiser BK, Fernandes TF, Jepson M, Lead JR, Tyler CR, Stone V. Assessing exposure, uptake and toxicity of silver and cerium dioxide nanoparticles from contaminated environments. Environ Health. 2009; 8 Suppl 1: S2. doi: 10.1186/1476-069X-8-S1-S2 PMID: 20102587
89. Gaiser BK, Fernandes TF, Jepson MA, Lead JR, Tyler CR, Baalousha M, et al. Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles. Environ Toxicol Chem. 2012; 31: 144-154. doi: 10.1002/etc.703 PMID: 22002553
90. Hussain S, Al-Nsour F, Rice AB, Marshburn J, Yingling B, Ji Z, et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano. 2012; 6: 5820-5829. doi: 10.1021/nn302235u PMID: 22717232
91. Verstraelen S, Remy S, Casals E, De Boever P, Witters H, Gatti A, et al. Gene expression profiles reveal distinct immunological responses of cobalt and cerium dioxide nanoparticles in two in vitro lung epithelial cell models. Toxicol Lett. 2014; 228: 157-169. doi: 10.1016/j.toxlet.2014.05.006 PMID: 24821434
92. Zhou X, Wang B, Chen Y, Mao Z, Gao C. Uptake of cerium oxide nanoparticles and their influences on functions of A549 cells. J Nanosci Nanotechnol. 2013; 13: 204-215. PMID: 23646718